The QUICKVUE Influenza + SARS Test from QuidelOrtho Corporation is designed to deliver rapid, simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2 antigens from a single patient sample, providing results in as fast as 10 minutes. This capability can help clinicians quickly distinguish between COVID-19 and seasonal flu infections, which present similar symptoms, enabling timely treatment decisions. Designed for CLIA-waived and moderate to high-complexity lab settings, the test enables workflow efficiency with an easy-to-collect nasal swab, straightforward processing, and a clear result window.